Try to understand how genetic variation in non-coding, regulatory DNA sequences alter islet gene expression to contribute to islet dysfunction and type 2 diabetes (T2D).
After working at Yale for seven years studying type 2 diabetes in obese adolescents, I came to JAX in 2014 to join the Stitzel lab. Using a broad spectrum of genetic and epigenetic techniques (e.g., ChIP-seq, RNA-seq, ChIA-PET, ATAC-seq) to study the epigenome of human islets and rodent beta-cell lines we are able to identify “stretch”enhancers involved in type 2 diabetes. By breaking them using CRISPR-Cas9 we will investigate altered gene expression and insulin signaling to understand their function.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.